Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ABEV | INST-CLUSTER | neutral | 3/10 | Three institutional investors increased their ABEV holdings in Q3 2026, led by a near-doubling by Robeco and meaningful | Oct 29, 2026 |
| DASH | 8-K | bullish | 6/10 | DoorDash reported Q3 2026 results with revenue of $4.616B (up 34% YoY) and GAAP diluted EPS of $1.06, both above consens | Oct 29, 2026 |
| TNET | 8-K | bearish | 5/10 | TriNet reported Q3 2026 revenue of $1.175B, down 5% YoY, and GAAP diluted EPS of $0.65, down from $0.70 in the prior yea | Oct 29, 2026 |
| ACB | 6-K | neutral | 2/10 | Aurora Cannabis filed a 6-K announcing the date of its fiscal Q2 2027 earnings release and investor conference call on N | Oct 29, 2026 |
| BAX | 8-K | bullish | 6/10 | Baxter reported Q3 2026 revenue of $2.976B, up 5% YoY, and adjusted EPS of $0.58, down 16% YoY due to a higher effective | Oct 29, 2026 |
| GMTL | 6-K | neutral | 2/10 | Guardian Metal Resources PLC filed a 6-K announcing an investor presentation scheduled for November 5, 2026, where manag | Oct 29, 2026 |
| VFS | 6-K | bullish | 5/10 | VinFast reported preliminary Q3 2026 EV deliveries of 82,580 units, up 116% year-over-year, and disclosed a $436.4 milli | Oct 29, 2026 |
| CCC | 8-K | neutral | 5/10 | CCC reported Q3 2026 revenue of $294.1M (+10.1% YoY) and GAAP EPS of $0.05, in line with consensus of $0.11 on an adjust | Oct 29, 2026 |
| LGND | 8-K | bullish | 6/10 | Ligand Pharmaceuticals reported Q3 2026 royalty revenue of $70.3M, up 51% year-over-year, driven by the XOMA portfolio a | Oct 29, 2026 |
| INDV | 425 | bullish | 5/10 | Indivior reported record Q3 2026 results with total net revenue up 13% YoY to $356M, record SUBLOCADE revenue up 22% YoY | Oct 29, 2026 |
| RAASY | SC 13E-3/A | mixed | 8/10 | This final amendment to Schedule 13E-3 reports that the going-private merger of Cloopen Group Holding Ltd became effecti | Oct 29, 2026 |
| LAUR | 8-K | bullish | 6/10 | Laureate Education reported Q3 2026 revenue of $485.1M (+21% YoY reported, +14% constant currency) and GAAP diluted EPS | Oct 29, 2026 |
| WTBA | 8-K | neutral | 5/10 | West Bancorporation reported Q3 2026 net income of $11.6 million ($0.67 diluted EPS), up 5.0% sequentially and 24.8% YoY | Oct 29, 2026 |
| TSAT | 6-K | bearish | 6/10 | Telesat reported Q3 2026 consolidated revenue of $81 million, a 20% decline YoY, and adjusted EBITDA of $12 million, a 7 | Oct 29, 2026 |
| FRFHF | 6-K | neutral | 4/10 | Fairfax Financial Holdings completed the sale of its 80% equity interest in Eurolife FFH Insurance Group Holdings S.A. t | Oct 29, 2026 |
| HOG | PRESS-RELEASE | bearish | 6/10 | Harley-Davidson reported Q3 2026 GAAP diluted EPS of $0.40, below the $0.47 consensus, and HDMC revenue of $964M, below | Oct 29, 2026 |
| LIN | 8-K | bullish | 6/10 | Linde reported Q3 2026 adjusted EPS of $4.59, beating the $4.52 consensus by 1.5%, and revenue of $9.404B, above the $9. | Oct 29, 2026 |
| CLX | DEFA14A | neutral | 3/10 | Clorox filed a DEFA14A supplement to its proxy statement disclosing the appointment of Fabian Garcia as CEO effective Ja | Oct 29, 2026 |
| OWL | 8-K | bullish | 6/10 | Blue Owl Capital reported Q3 2026 Fee-Related Earnings of $427.5M ($0.27 per adjusted share) and Distributable Earnings | Oct 29, 2026 |
| KYMR | 8-K | neutral | 5/10 | Kymera Therapeutics reported Q3 2026 results with no collaboration revenue ($0 vs $2.8M in Q3 2025) and a net loss of $1 | Oct 29, 2026 |
| AXTA | 8-K | bearish | 5/10 | Axalta reported Q3 2026 net sales of $1.311B, up 2% YoY, but Adjusted EBITDA fell 4% to $282M and Adjusted Diluted EPS d | Oct 29, 2026 |
| ALGM | 8-K | bullish | 6/10 | Allegro MicroSystems reported fiscal Q2 2027 revenue of $276.9M (+29% YoY) and non-GAAP EPS of $0.26, beating consensus | Oct 29, 2026 |
| HII | 8-K | bullish | 6/10 | HII reported record Q3 2026 revenue of $3.537B (+10.8% YoY) and diluted EPS of $5.48 (+48.9% YoY), both significantly ab | Oct 29, 2026 |
| CRTO | 8-K | neutral | 2/10 | Criteo announced the resignation of board member Edmond Mesrobian and the appointment of Jianchang 'JC' Mao as an indepe | Oct 29, 2026 |
| CLX | 8-K | neutral | 3/10 | Clorox appointed Fabian Garcia as CEO, effective January 5, 2027, succeeding Linda Rendle who is stepping down for healt | Oct 29, 2026 |
| WST | 8-K | bullish | 6/10 | West Pharmaceutical reported Q3 2026 net sales of $874.5M (+8.7% reported, +11.9% organic) and adjusted-diluted EPS of $ | Oct 29, 2026 |
| CSIQ | 6-K | bearish | 6/10 | Canadian Solar's majority-owned subsidiary CSI Solar reported a severe Q3 2026 earnings decline. Operating revenue fell | Oct 29, 2026 |
| BMY | 8-K | neutral | 5/10 | Bristol Myers Squibb reported Q3 2026 revenue of $13.07B (+7% YoY), above the $12.73B consensus, driven by 12% Growth Po | Oct 29, 2026 |
| BCYC | 8-K | neutral | 4/10 | Bicycle Therapeutics reported Q3 2026 net loss of $10.5M ($-0.15 per share), significantly narrower than the $59.1M loss | Oct 29, 2026 |
| TROW | 8-K | mixed | 5/10 | T. Rowe Price reported Q3 2026 adjusted EPS of $2.86, beating the $2.65 consensus by 7.9%, and revenue of $2.005B, above | Oct 29, 2026 |